Table 1: Independent Predictors of Post-discharge Mortality in Registries.
Registry | Year of publication | Sample size | Prediction period | Independent predictor results from multivariate analysis |
---|---|---|---|---|
OPTIMIZE-HF[9] | 2008 | 4400 | 60-day mortality | Creatinine; sodium; age; HR; liver disease; previous CVA/TIA; peripheral vascular disease; race; left ventricular systolic dysfunction; COPD; SBP; previous HF hospitalisation |
EFICA[11] | 2006 | 599 | 1-month and 12-month mortality | Shock; renal dysfunction; ischaemia; liver dysfunction; previous ADHF episode; comorbidity; SBP; pulmonary oedema |
MOCA[12]12 | 2013 | 5306 | 1-month and 12-month mortality | Age; sex; SBP and DBP; eGFR; sodium; haemoglobin; heart rate; NT-proBNP; CRP; MR-proADM; sST2 |
FINN AKVA[13] | 2006 | 620 | age, male gender; lower systolic blood pressure (SBP) on admission; C-reactive protein and serum creatinine >120 mmol/L |
|
ESC-HF-LT registry[14] | 2016 | 5039 | 1-year mortality | Age; SBP; EF; NYHA III–IV; congestion; aortic stenosis; diabetes; COPD; previous stroke; renal dysfunction; hepatic dysfunction |
AHEAD[15] | 2011 | 3438 | 1-year mortality | Age; creatinine; valvular disease; LVEF <30 %; previous stroke or TIA; de novo vs worsening chronic HF |
IN-HF[16] | 2013 | 1855 | 1-year mortality | Age; low SBP; somnolent or confused; Na <136 mEq/l; creatinine >1.5 mg/dl; BUN >50 mg/dl; Hb <12 g/dl; APE; COPD |
ADHF = acute decompensated heart failure; AHEAD = Acute Heart Failure Database; APE = acute pulmonary embolism; BUN = blood urea nitrogen; COPD = chronic obstructive pulmonar disease; CRP = C-reactive protein; CVA/TIA = cerebrovascular accident/transitory ischaemic accident; DBP = diastolic blood pressure; EF = ejection fraction; EFICA = Etude Francaise de l’Insuffisance Cardiaque Aigue; eGFR = estimated glomerular filtration rate; ELAN = European Collaboration on Acute Decompensated Heart Failure; ESC HF LT = European Society of Cardiology Heart Failure Long-Term Registry; FINN AKVA = Finnish Acute Heart Failure Study; Hb = haemoglobin; HF = heart failure; HR = heart rate; IN HF = Italian Network on Heart Failure; LVEF = left ventricular ejection fraction; MOCA = Multinational Observational Cohort on Acute Heart Failure; MR-proADM = mid-regional pro-adrenomedullin; NT-proBNP = N-terminal pro brain natriuretic peptide; NYHA = New York Heart Association; OPTIMIZE-HF = Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure; SBP = systolic blood pressure; sST2 = soluble suppression of tumorigenicity 2.